rizatriptan has been researched along with telcagepant in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, IM | 1 |
| Ashina, M; Jensen, RH | 1 |
| Ashina, M; Aurora, SK; Connor, KM; Giezek, H; Ho, TW; Jones, C; Lines, C; Loeys, T; Massaad, R; Williams-Diaz, A | 1 |
| Cui, XP; Lin, H; Lin, M; Mu, JS; Ye, JX | 1 |
2 review(s) available for rizatriptan and telcagepant
| Article | Year |
|---|---|
Calcitonin gene-related peptide receptor antagonists: new therapeutic agents for migraine.
Topics: Amino Acid Sequence; Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Clinical Trials as Topic; Drug Discovery; Humans; Migraine Disorders; Molecular Sequence Data; Receptors, Calcitonin Gene-Related Peptide; Structure-Activity Relationship | 2014 |
Efficacy, safety, and tolerability of telcagepant in the treatment of acute migraine: a meta-analysis.
Topics: Acute Disease; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Humans; Imidazoles; Migraine Disorders; Oxazolidinones; Serotonin 5-HT1 Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2015 |
1 trial(s) available for rizatriptan and telcagepant
| Article | Year |
|---|---|
Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial.
Topics: Adult; Aged; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Double-Blind Method; Endpoint Determination; Female; Humans; Imidazoles; Male; Middle Aged; Migraine Disorders; Triazoles; Tryptamines | 2011 |
1 other study(ies) available for rizatriptan and telcagepant
| Article | Year |
|---|---|
[A new therapeutic principle for migraine].
Topics: Azepines; Calcitonin Gene-Related Peptide; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; Vasodilator Agents | 2008 |